Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said in a release Wednesday.
Related Posts
Covid-19 boosters could keep thousands of kids out of hospitals, but uptake remains low
Higher Covid-19 vaccination rates among US childre
The NFL and players’ union agree to suspend COVID protocols for the 2022 season
With the change in protocol, league players an
What is male factor infertility, and how can it be treated?
A 2020 study found that when a couple tries to get